HMMR Antisense RNA 1, a Novel Long Noncoding RNA, Regulates the Progression of Basal-like Breast Cancer Cells

Overview

Journal Breast Cancer (Dove Med Press)

Publisher Dove Medical Press

Date 2016 Dec 7

PMID 27920576

Citations 17

Authors

Wei Liu

Jun Ma

Yong Cheng

Hongbo Zhang

Wengguang Luo

Hongyan Zhang

Affiliations

Soon will be listed here.

Abstract

Recently, accumulating evidence has suggested that long noncoding RNAs (lncRNAs) play crucial roles in carcinogenesis and cancer progression. Hyaluronan-mediated motility receptor (HMMR) is an essential cancer-related gene in basal-like breast cancer (BLBC). In our study, HMMR antisense RNA 1 (HMMR-AS1) was analyzed in BLBC patients through polymerase chain reaction analysis. Here, we found that the expression of HMMR was positively correlated with HMMR-AS1 (RP11-80G.1). When HMMR-AS1 (RP11-80G.1) was knocked down, the expression of HMMR markedly reduced. Furthermore, in MDA-MB-231 and MDA-MB-468 breast cancer cells, the proliferation and migration abilities were remarkably suppressed via knocking down HMMR-AS1 (RP11-80G.1) in vitro. The results showed that lncRNA HMMR-AS1 (RP11-80G.1) influenced the progression of BLBCs through regulating HMMR, suggesting that HMMR-AS1 (RP11-80G.1) could be regarded as a novel biomarker and therapeutic target in the treatment of BLBCs in future.

Citing Articles

Radiotherapy and breast cancer: finally, an lncRNA perspective on radiosensitivity and radioresistance.

Yazarlou F, Martinez I, Lipovich L Front Oncol. 2024; 14:1437542.

PMID: 39346726 PMC: 11427263. DOI: 10.3389/fonc.2024.1437542.

Identification of disease-related aberrantly spliced transcripts in myeloma and strategies to target these alterations by RNA-based therapeutics.

Ogiya D, Chyra Z, Verselis S, OKeefe M, Cobb J, Abiatari I Blood Cancer J. 2023; 13(1):23.

PMID: 36737429 PMC: 9898564. DOI: 10.1038/s41408-023-00791-0.

HMMR potential as a diagnostic and prognostic biomarker of cancer-speculation based on a pan-cancer analysis.

Shang J, Zhang X, Hou G, Qi Y Front Surg. 2023; 9:998598.

PMID: 36704516 PMC: 9873350. DOI: 10.3389/fsurg.2022.998598.

Coding roles of long non-coding RNAs in breast cancer: Emerging molecular diagnostic biomarkers and potential therapeutic targets with special reference to chemotherapy resistance.

Kashyap D, Sharma R, Goel N, Buttar H, Garg V, Pal D Front Genet. 2023; 13:993687.

PMID: 36685962 PMC: 9852779. DOI: 10.3389/fgene.2022.993687.

The hypoxia-driven crosstalk between tumor and tumor-associated macrophages: mechanisms and clinical treatment strategies.

Bai R, Li Y, Jian L, Yang Y, Zhao L, Wei M Mol Cancer. 2022; 21(1):177.

PMID: 36071472 PMC: 9454207. DOI: 10.1186/s12943-022-01645-2.

References

Perez D, Hoage T, Pritchett J, Ducharme-Smith A, Halling M, Ganapathiraju S . Long, abundantly expressed non-coding transcripts are altered in cancer. Hum Mol Genet. 2007; 17(5):642-55. DOI: 10.1093/hmg/ddm336. View

Hatano H, Shigeishi H, Kudo Y, Higashikawa K, Tobiume K, Takata T . Overexpression of receptor for hyaluronan-mediated motility (RHAMM) in MC3T3-E1 cells induces proliferation and differentiation through phosphorylation of ERK1/2. J Bone Miner Metab. 2011; 30(3):293-303. DOI: 10.1007/s00774-011-0318-0. View

Blanco I, Kuchenbaecker K, Cuadras D, Wang X, Barrowdale D, Ruiz de Garibay G . Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers. PLoS One. 2015; 10(4):e0120020. PMC: 4382299. DOI: 10.1371/journal.pone.0120020. View

Han L, Zhang K, Shi Z, Zhang J, Zhu J, Zhu S . LncRNA proﬁle of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis. Int J Oncol. 2012; 40(6):2004-12. DOI: 10.3892/ijo.2012.1413. View

Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H . The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012; 22(9):1775-89. PMC: 3431493. DOI: 10.1101/gr.132159.111. View

Maxwell C, Benitez J, Gomez-Baldo L, Osorio A, Bonifaci N, Fernandez-Ramires R . Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer. PLoS Biol. 2011; 9(11):e1001199. PMC: 3217025. DOI: 10.1371/journal.pbio.1001199. View

Guttman M, Amit I, Garber M, French C, Lin M, Feldser D . Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature. 2009; 458(7235):223-7. PMC: 2754849. DOI: 10.1038/nature07672. View

Jacquier A . The complex eukaryotic transcriptome: unexpected pervasive transcription and novel small RNAs. Nat Rev Genet. 2009; 10(12):833-44. DOI: 10.1038/nrg2683. View

Wahlestedt C . Natural antisense and noncoding RNA transcripts as potential drug targets. Drug Discov Today. 2006; 11(11-12):503-8. DOI: 10.1016/j.drudis.2006.04.013. View

10.

Redis R, Sieuwerts A, Look M, Tudoran O, Ivan C, Spizzo R . CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations. Oncotarget. 2013; 4(10):1748-62. PMC: 3858561. DOI: 10.18632/oncotarget.1292. View

11.

Yelin R, Dahary D, Sorek R, Levanon E, Goldstein O, Shoshan A . Widespread occurrence of antisense transcription in the human genome. Nat Biotechnol. 2003; 21(4):379-86. DOI: 10.1038/nbt808. View

12.

Koelzer V, Huber B, Mele V, Iezzi G, Trippel M, Karamitopoulou E . Expression of the hyaluronan-mediated motility receptor RHAMM in tumor budding cells identifies aggressive colorectal cancers. Hum Pathol. 2015; 46(11):1573-81. DOI: 10.1016/j.humpath.2015.07.010. View

13.

Rakha E, Reis-Filho J, Ellis I . Basal-like breast cancer: a critical review. J Clin Oncol. 2008; 26(15):2568-81. DOI: 10.1200/JCO.2007.13.1748. View

14.

Akenteva N, Shushanov S, Kotelnikov A . Effects of RHAMM/HMMR-Selective Peptides on Survival of Breast Cancer Cells. Bull Exp Biol Med. 2015; 159(5):658-61. DOI: 10.1007/s10517-015-3041-3. View

15.

Kreike B, Van Kouwenhove M, Horlings H, Weigelt B, Peterse H, Bartelink H . Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas. Breast Cancer Res. 2007; 9(5):R65. PMC: 2242660. DOI: 10.1186/bcr1771. View

16.

Misra S, Hascall V, Markwald R, Ghatak S . Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer. Front Immunol. 2015; 6:201. PMC: 4422082. DOI: 10.3389/fimmu.2015.00201. View

17.

Spizzo R, Almeida M, Colombatti A, Calin G . Long non-coding RNAs and cancer: a new frontier of translational research?. Oncogene. 2012; 31(43):4577-87. PMC: 3433647. DOI: 10.1038/onc.2011.621. View

18.

Shtivelman E, Bishop J . Effects of translocations on transcription from PVT. Mol Cell Biol. 1990; 10(4):1835-9. PMC: 362296. DOI: 10.1128/mcb.10.4.1835-1839.1990. View

19.

Tilghman J, Wu H, Sang Y, Shi X, Guerrero-Cazares H, Quinones-Hinojosa A . HMMR maintains the stemness and tumorigenicity of glioblastoma stem-like cells. Cancer Res. 2014; 74(11):3168-79. PMC: 4059010. DOI: 10.1158/0008-5472.CAN-13-2103. View

20.

Guan Y, Kuo W, Stilwell J, Takano H, Lapuk A, Fridlyand J . Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer. Clin Cancer Res. 2007; 13(19):5745-55. DOI: 10.1158/1078-0432.CCR-06-2882. View